Massimo Cristofanilli, M.D., Deputy Director of Translational Research at the Kimmel Cancer Center and director of the Breast Care Center at Thomas Jefferson University Hospital. He is an expert in molecular diagnostics in breast cancer and he can discuss his first-hand experience assessing cancer genomes to find alternative therapies that might extend patient survival. His investigations using genomics in evaluating patients with inflammatory breast cancer, the most aggressive and deadly form of breast cancer, have revealed unexpected opportunities for therapy. He can also discuss the findings of the recent Institute of Medicine (IOM) report on genome-based diagnostics.
Renu Bajaj, Ph.D., director of the cytogenetics program and Zi-Xuan (Zoe) Wang, Ph.D., both in the department of Pathology, Anatomy and Cell Biology at Thomas Jefferson University. Together, Drs. Wang, and Bajaj are developing a genomics-profiling service for physicians at Jefferson. The service would put genome-based diagnostics at the fingertips of physicians interested in finding alternative therapies for their patients. They are available to discuss this project in context of the recent IOM report.
RSS